Literature DB >> 27099579

Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies.

Zilla H Hussain1, Kelly Everhart1, Brian E Lacy1.   

Abstract

Constipation is a highly prevalent disorder that affects people regardless of age, race, gender, or socioeconomic status. For many patients, constipation is a chronic condition that reduces quality of life. Chronic constipation also imposes a significant economic burden on the health care system. The treatment of constipation remains problematic for both patients and providers for a variety of reasons, including a lack of specificity of symptoms, an inconsistent relationship between underlying pathophysiology and symptom generation, and different and unpredictable patient responses to medications. A large number of over-the-counter agents are used to treat symptoms of constipation, although many of these agents are not effective, and data to support their use are limited and generally of poor quality. Patients referred for consultation typically have failed therapy with over-the-counter agents and require prescription medications or possibly even surgical therapy. This article discusses medical treatments and surgical options for chronic idiopathic constipation.

Entities:  

Keywords:  Chronic constipation; bile acid—modifying agents; chenodeoxycholic acid; linaclotide; lubiprostone; sacral nerve stimulation; tegaserod

Year:  2015        PMID: 27099579      PMCID: PMC4836568     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  55 in total

1.  Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study.

Authors:  M Goldberg; Y-P Li; J F Johanson; A W Mangel; M Kitt; D T Beattie; K Kersey; O Daniels
Journal:  Aliment Pharmacol Ther       Date:  2010-09-22       Impact factor: 8.171

2.  Functional outcome of sacral nerve stimulation in patients with severe constipation.

Authors:  Héctor Ortiz; Mario de Miguel; Marcella Rinaldi; Fabiola Oteiza; Donato F Altomare
Journal:  Dis Colon Rectum       Date:  2012-08       Impact factor: 4.585

3.  Prospective randomized double-blind study of temporary sacral nerve stimulation in patients with rectal evacuatory dysfunction and rectal hyposensitivity.

Authors:  Charles H Knowles; Noel Thin; Katherine Gill; Chetan Bhan; Karyn Grimmer; Peter J Lunniss; Norman S Williams; S Mark Scott
Journal:  Ann Surg       Date:  2012-04       Impact factor: 12.969

Review 4.  Review article: epidemiology and quality of life in functional gastrointestinal disorders.

Authors:  L Chang
Journal:  Aliment Pharmacol Ther       Date:  2004-11       Impact factor: 8.171

5.  Randomised clinical trial: The ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation--a double-blind study.

Authors:  M Simrén; A Bajor; P-G Gillberg; M Rudling; H Abrahamsson
Journal:  Aliment Pharmacol Ther       Date:  2011-05-05       Impact factor: 8.171

6.  Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract.

Authors:  Alexander P Bryant; Robert W Busby; Wilmin P Bartolini; Etchell A Cordero; Gerhard Hannig; Marco M Kessler; Christine M Pierce; Robert M Solinga; Jenny V Tobin; Shalina Mahajan-Miklos; Mitchell B Cohen; Caroline B Kurtz; Mark G Currie
Journal:  Life Sci       Date:  2010-03-20       Impact factor: 5.037

7.  SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents.

Authors:  John Cuppoletti; Danuta H Malinowska; Kirti P Tewari; Qiu-Ju Li; Ann M Sherry; Myra L Patchen; Ryuji Ueno
Journal:  Am J Physiol Cell Physiol       Date:  2004-06-22       Impact factor: 4.249

8.  Electrically stimulated colonic reservoir for total anorectal reconstruction.

Authors:  S F Hughes; S M Scott; M A Pilot; N S Williams
Journal:  Br J Surg       Date:  1995-10       Impact factor: 6.939

9.  A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation.

Authors:  William D Chey; Michael Camilleri; Lin Chang; Leif Rikner; Hans Graffner
Journal:  Am J Gastroenterol       Date:  2011-05-24       Impact factor: 10.864

10.  Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation.

Authors:  Anthony J Lembo; John F Johanson; Henry P Parkman; Satish S Rao; Philip B Miner; Ryuji Ueno
Journal:  Dig Dis Sci       Date:  2011-07-19       Impact factor: 3.199

View more
  4 in total

Review 1.  Constipation: Evaluation and Management.

Authors:  Bhairvi Jani; Elizabeth Marsicano
Journal:  Mo Med       Date:  2018 May-Jun

Review 2.  Review article: diagnosis, management and patient perspectives of the spectrum of constipation disorders.

Authors:  Amol Sharma; Satish S C Rao; Kimberly Kearns; Kimberly D Orleck; Scott A Waldman
Journal:  Aliment Pharmacol Ther       Date:  2021-04-28       Impact factor: 8.171

3.  Pharmacological Inhibition of the Voltage-Gated Sodium Channel NaV1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome.

Authors:  Yan Jiang; Joel Castro; Linda V Blomster; Akello J Agwa; Jessica Maddern; Gudrun Schober; Volker Herzig; Chun Yuen Chow; Fernanda C Cardoso; Paula Demétrio De Souza França; Junior Gonzales; Christina I Schroeder; Steffen Esche; Thomas Reiner; Stuart M Brierley; Glenn F King
Journal:  ACS Pharmacol Transl Sci       Date:  2021-06-07

4.  Subtotal colectomy with antiperistaltic cecosigmoidal anastomosis may be another suitable option for slow transit constipation: Experiences from Chinese people.

Authors:  Yong-Ping Yang; Jian Shi; Ze-Yun Zhao; Ling-Yun Yu; Tong-Jun Liu
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.